Costs of Healthcare- and Community-Associated Infections With Antimicrobial-Resistant Versus Antimicrobial-Susceptible Organisms

被引:167
作者
Neidell, Matthew J. [2 ]
Cohen, Bevin [1 ]
Furuya, Yoko [3 ]
Hill, Jennifer [4 ]
Jeon, Christie Y. [1 ]
Glied, Sherry [2 ]
Larson, Elaine L. [1 ,2 ]
机构
[1] Columbia Univ, Sch Nursing, New York, NY 10032 USA
[2] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA
[3] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA
[4] NYU, Steinhardt Sch Educ, New York, NY USA
关键词
BLOOD-STREAM INFECTIONS; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; METHICILLIN-RESISTANCE; ANTIBIOTIC-RESISTANCE; EUROPEAN HOSPITALS; MORTALITY; ENTEROCOCCUS; BACTEREMIA; BURDEN;
D O I
10.1093/cid/cis552
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective. We compared differences in the hospital charges, length of hospital stay, and mortality between patients with healthcare- and community-associated bloodstream infections, urinary tract infections, and pneumonia due to antimicrobial-resistant versus -susceptible bacterial strains. Methods. A retrospective analysis of an electronic database compiled from laboratory, pharmacy, surgery, financial, and patient location and device utilization sources was undertaken on 5699 inpatients who developed healthcare- or community-associated infections between 2006 and 2008 from 4 hospitals (1 community, 1 pediatric, 2 tertiary/quaternary care) in Manhattan. The main outcome measures were hospital charges, length of stay, and mortality among patients with antimicrobial-resistant and -susceptible infections caused by Staphylococcus aureus, Enterococcus faecium, Enterococcus faecalis, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. Results. Controlling for multiple confounders using linear regression and nearest neighbor matching based on propensity score estimates, resistant healthcare- and community-associated infections, when compared with susceptible strains of the same organism, were associated with significantly higher charges ($15 626; confidence interval [CI], $4339-$26 913 and $25 573; CI, $9331-$41 816, respectively) and longer hospital stays for community-associated infections (3.3; CI, 1.5-5.4). Patients with resistant healthcare-associated infections also had a significantly higher death rate (0.04; CI, 0.01-0.08). Conclusions. With careful matching of patients infected with the same organism, antimicrobial resistance was associated with higher charges, length of stay, and death rates. The difference in estimates after accounting for censoring for death highlight divergent social and hospital incentives in reducing patient risk for antimicrobial resistant infections.
引用
收藏
页码:807 / 815
页数:9
相关论文
共 40 条
[1]   The additional costs of antibiotics and re-consultations for antibiotic-resistant Escherichia coli urinary tract infections managed in general practice [J].
Alam, M. Fasihul ;
Cohen, David ;
Butler, Christopher ;
Dunstan, Frank ;
Roberts, Zoe ;
Hillier, Sharon ;
Palmer, Stephen .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 (03) :255-257
[2]   Antibiotic resistance and its cost: is it possible to reverse resistance? [J].
Andersson, Dan I. ;
Hughes, Diarmaid .
NATURE REVIEWS MICROBIOLOGY, 2010, 8 (04) :260-271
[3]   Using Electronically Available Inpatient Hospital Data for Research [J].
Apte, Mandar ;
Neidell, Matthew ;
Furuya, E. Yoko ;
Caplan, David ;
Glied, Sherry ;
Larson, Elaine .
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2011, 4 (05) :338-345
[4]   Are There Differences in Hospital Cost Between Patients With Nosocomial Methicillin-Resistant Staphylococcus aureus Bloodstream Infection and Those With Methicillin-Susceptible S-aureus Bloodstream Infection? [J].
Ben-David, Debby ;
Novikov, Ilya ;
Mermel, Leonard A. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (05) :453-460
[5]   Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America [J].
Boucher, Helen W. ;
Talbot, George H. ;
Bradley, John S. ;
Edwards, John E., Jr. ;
Gilbert, David ;
Rice, Louis B. ;
Scheld, Michael ;
Spellberg, Brad ;
Bartlett, John .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) :1-12
[6]   Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08 [J].
Bourdon, Nancy ;
Fines-Guyon, Marguerite ;
Thiolet, Jean-Michel ;
Maugat, Sylvie ;
Coignard, Bruno ;
Leclercq, Roland ;
Cattoir, Vincent .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (04) :713-721
[7]   Rapid screening for carriage of methicillin-resistant Staphylococcus aureus by PCR and associated costs [J].
Buehlmann, Manuela ;
Boegli-Stuber, Katja ;
Droz, Sara ;
Muehlemann, Kathrin .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (07) :2151-2154
[8]   Attributable Costs of Enterococcal Bloodstream Infections in a Nonsurgical Hospital Cohort [J].
Butler, Anne M. ;
Olsen, Margaret A. ;
Merz, Liana R. ;
Guth, Rebecca M. ;
Woeltje, Keith F. ;
Camins, Bernard C. ;
Fraser, Victoria J. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (01) :28-35
[9]   National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 [J].
Cardo, D ;
Horan, T ;
Andrus, M ;
Dembinski, M ;
Edwards, J ;
Peavy, G ;
Tolson, J ;
Wagner, D .
AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) :470-485
[10]   Behavior Change Strategies to Influence Antimicrobial Prescribing in Acute Care: A Systematic Review [J].
Charani, Esmita ;
Edwards, Rachel ;
Sevdalis, Nick ;
Alexandrou, Banos ;
Sibley, Eleanor ;
Mullett, David ;
Franklin, Bryony Dean ;
Holmes, Alison .
CLINICAL INFECTIOUS DISEASES, 2011, 53 (07) :651-662